Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligases
- PMID: 23085373
- PMCID: PMC3628764
- DOI: 10.1016/j.bbamcr.2012.10.010
Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligases
Abstract
Protein tyrosine kinases (PTKs) coordinate a broad spectrum of cellular responses to extracellular stimuli and cell-cell interactions during development, tissue homeostasis, and responses to environmental challenges. Thus, an understanding of the regulatory mechanisms that ensure physiological PTK function and potential aberrations of these regulatory processes during diseases such as cancer are of broad interest in biology and medicine. Aside from the expected role of phospho-tyrosine phosphatases, recent studies have revealed a critical role of covalent modification of activated PTKs with ubiquitin as a critical mechanism of their negative regulation. Members of the Cbl protein family (Cbl, Cbl-b and Cbl-c in mammals) have emerged as dominant "activated PTK-selective" ubiquitin ligases. Structural, biochemical and cell biological studies have established that Cbl protein-dependent ubiquitination targets activated PTKs for degradation either by facilitating their endocytic sorting into lysosomes or by promoting their proteasomal degradation. This mechanism also targets PTK signaling intermediates that become associated with Cbl proteins in a PTK activation-dependent manner. Cellular and animal studies have established that the relatively broadly expressed mammalian Cbl family members Cbl and Cbl-b play key physiological roles, including their critical functions to prevent the transition of normal immune responses into autoimmune disease and as tumor suppressors; the latter function has received validation from human studies linking mutations in Cbl to human leukemia. These newer insights together with embryonic lethality seen in mice with a combined deletion of Cbl and Cbl-b genes suggest an unappreciated role of the Cbl family proteins, and by implication the ubiquitin-dependent control of activated PTKs, in stem/progenitor cell maintenance. Future studies of existing and emerging animal models and their various cell lineages should help test the broader implications of the evolutionarily-conserved Cbl family protein-mediated, ubiquitin-dependent, negative regulation of activated PTKs in physiology and disease.
Copyright © 2012 Elsevier B.V. All rights reserved.
Figures
Similar articles
-
The Cbl family proteins: ring leaders in regulation of cell signaling.J Cell Physiol. 2006 Oct;209(1):21-43. doi: 10.1002/jcp.20694. J Cell Physiol. 2006. PMID: 16741904 Review.
-
The Cbl family of ubiquitin ligases: critical negative regulators of tyrosine kinase signaling in the immune system.J Leukoc Biol. 2002 May;71(5):753-63. J Leukoc Biol. 2002. PMID: 11994499 Review.
-
Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders.Oncotarget. 2011 Mar;2(3):245-50. doi: 10.18632/oncotarget.233. Oncotarget. 2011. PMID: 21422499 Free PMC article.
-
Negative regulation of receptor tyrosine kinases by ubiquitination: Key roles of the Cbl family of E3 ubiquitin ligases.Front Endocrinol (Lausanne). 2022 Jul 28;13:971162. doi: 10.3389/fendo.2022.971162. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35966060 Free PMC article. Review.
-
Negative regulation of Lck by Cbl ubiquitin ligase.Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3794-9. doi: 10.1073/pnas.062055999. Proc Natl Acad Sci U S A. 2002. PMID: 11904433 Free PMC article.
Cited by
-
E3 Ubiquitin Ligases: Potential Therapeutic Targets for Skeletal Pathology and Degeneration.Stem Cells Int. 2022 Sep 27;2022:6948367. doi: 10.1155/2022/6948367. eCollection 2022. Stem Cells Int. 2022. PMID: 36203882 Free PMC article. Review.
-
PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371.Blood. 2023 Jan 19;141(3):244-259. doi: 10.1182/blood.2022016580. Blood. 2023. PMID: 36206490 Free PMC article.
-
c-Cbl mediates the degradation of tumorigenic nuclear β-catenin contributing to the heterogeneity in Wnt activity in colorectal tumors.Oncotarget. 2016 Nov 1;7(44):71136-71150. doi: 10.18632/oncotarget.12107. Oncotarget. 2016. PMID: 27661103 Free PMC article.
-
Semantic clustering analysis of E3-ubiquitin ligases in gastrointestinal tract defines genes ontology clusters with tissue expression patterns.BMC Gastroenterol. 2022 Apr 12;22(1):186. doi: 10.1186/s12876-022-02265-2. BMC Gastroenterol. 2022. PMID: 35413796 Free PMC article.
-
Post-Translational Modifications in Atopic Dermatitis: Current Research and Clinical Relevance.Front Cell Dev Biol. 2022 Jul 7;10:942838. doi: 10.3389/fcell.2022.942838. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35874824 Free PMC article. Review.
References
-
- Weiss A. The right team at the right time to go for a home run: tyrosine kinase activation by the TCR. Nat. Immunol. 2010;11:101–104. - PubMed
-
- Hendriks WJ, Elson A, Harroch S, Stoker AW. Protein tyrosine phosphatases: functional inferences from mouse models and human diseases. FEBS J. 2008;275:816–830. - PubMed
-
- Julien SG, Dube N, Hardy S, Tremblay ML. Inside the human cancer tyrosine phosphatome. Nat. Rev. Cancer. 2011;11:35–49. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA087986/CA/NCI NIH HHS/United States
- CA105489/CA/NCI NIH HHS/United States
- R01 CA096844/CA/NCI NIH HHS/United States
- U01 CA151806/CA/NCI NIH HHS/United States
- CA116552/CA/NCI NIH HHS/United States
- R01 CA116552/CA/NCI NIH HHS/United States
- CA009476/CA/NCI NIH HHS/United States
- CA99163/CA/NCI NIH HHS/United States
- R01 CA099163/CA/NCI NIH HHS/United States
- CA87986/CA/NCI NIH HHS/United States
- R01 CA144027/CA/NCI NIH HHS/United States
- R01 CA105489/CA/NCI NIH HHS/United States
- T32 CA009476/CA/NCI NIH HHS/United States
- 5U01CA151806-02/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
